StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen total current assets ($M) ($M)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, FY2025
29,057
Period ended Dec 31, 2025
Change on a year earlier
+0.1%
29,030 in FY2024
History
18 years
Since FY2008
Sources
18
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal current assets ($M) ($M)Year on yearSource
FY2025Dec 31, 202529,057+0.1%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 202429,030-4.3%Form 10-K (filed 2025-02-14) ↗
FY2023Dec 31, 202330,332+36.7%Form 10-K (filed 2024-02-14) ↗
FY2022Dec 31, 202222,186+14.4%Form 10-K (filed 2023-02-09) ↗
FY2021Dec 31, 202119,385-8.3%Form 10-K (filed 2022-02-16) ↗
FY2020Dec 31, 202021,144+14.7%Form 10-K (filed 2021-02-09) ↗
FY2019Dec 31, 201918,440-51.0%Form 10-K (filed 2020-02-12) ↗
FY2018Dec 31, 201837,618-24.0%Form 10-K (filed 2019-02-13) ↗
FY2017Dec 31, 201749,476+7.5%Form 10-K (filed 2018-02-13) ↗
FY2016Dec 31, 201646,010+19.5%Form 10-K (filed 2017-02-14) ↗
FY2015Dec 31, 201538,515+11.0%Form 10-Q (filed 2016-05-02) ↗
FY2014Dec 31, 201434,713+26.8%Form 10-K (filed 2015-02-19) ↗
FY2013Dec 31, 201327,367-12.3%Form 10-K (filed 2014-02-24) ↗
FY2012Dec 31, 201231,209+13.1%Form 10-K (filed 2013-02-27) ↗
FY2011Dec 31, 201127,593+19.3%Form 10-K (filed 2012-02-29) ↗
FY2010Dec 31, 201023,129+22.2%Form 10-K (filed 2011-02-25) ↗

Cite this data

StockData. (2026). Amgen Total current assets ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_ca

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.